51 SPXIQ

VRTX Vertex Pharmaceuticals Incorporated

Healthcare · Biotechnology

$494.07 +7.9% upside
Mean Target
$532.96
Consensus
1.7 - Buy
Analysts
27
Rank
#251 / 499
Upside Rank
#293
Analyst Price Target Distribution
$330
Low
$546
Median
$533
Mean
$625
High
Current $494
Mean $533
Median $546
93 estimates
Consensus
1.7 - Buy
52-Wk Low
$362.50
52-Wk High
$519.68
50-Day Avg
$465.70
Recent Analyst Ratings
FirmRatingTargetPriorDate
Canaccord Genuity Hold $441 $411 2026-02-17
Barclays Overweight $607 $606 2026-02-17
HC Wainwright & Co. Buy $591 $518 2026-02-17
Scotiabank Sector Perform $558 $495 2026-02-13
RBC Capital Outperform $541 $546 2026-02-13
Healthcare Peers
ABT ABBV A ALGN AMGN BAX BDX TECH BIIB BSX BMY CAH CNC COR CRL CI COO CVS DHR DVA DXCM EW ELV GEHC